NUVB (STOCKS)
Nuvation Bio Inc.
$4.738000
+0.138000 (+3.00%)
Prev close: $4.600000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- David T. Hung
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,633.71M
- Employees
- 291
- P/E (TTM)
- -7.84
- P/B (TTM)
- 5.08
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $62.90M |
| Benefits Costs and Expenses | $267.53M |
| Costs And Expenses | $267.53M |
| Nonoperating Income/Loss | $8.44M |
| Operating Expenses | $275.97M |
| Selling, General, and Administrative Expenses | $151.56M |
| Depreciation and Amortization | $1.74M |
| Research and Development | $115.11M |
| Other Operating Expenses | $7.56M |
| Operating Income/Loss | -$213.06M |
| Income/Loss From Continuing Operations After Tax | -$204.63M |
| Income/Loss From Continuing Operations Before Tax | -$204.63M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$204.63M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$204.63M |
| Net Income/Loss Available To Common Stockholders, Basic | -$204.63M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.60 |
| Diluted Earnings Per Share | -$0.60 |
| Basic Average Shares | 341,541 |
| Diluted Average Shares | 341,541 |
| Assets | $594.82M |
| Current Assets | $571.52M |
| Inventory | $11.41M |
| Other Current Assets | $560.11M |
| Noncurrent Assets | $23.30M |
| Fixed Assets | $564.00K |
| Other Non-current Assets | $22.74M |
| Liabilities | $289.11M |
| Current Liabilities | $82.23M |
| Accounts Payable | $9.48M |
| Other Current Liabilities | $72.75M |
| Noncurrent Liabilities | $206.88M |
| Long-term Debt | $47.21M |
| Other Non-current Liabilities | $159.67M |
| Equity | $305.72M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $305.72M |
| Liabilities And Equity | $594.82M |
| Net Cash Flow From Operating Activities | -$173.43M |
| Net Cash Flow From Operating Activities, Continuing | -$173.43M |
| Net Cash Flow From Investing Activities | $99.52M |
| Net Cash Flow From Investing Activities, Continuing | $99.52M |
| Net Cash Flow From Financing Activities | $202.54M |
| Net Cash Flow From Financing Activities, Continuing | $202.54M |
| Exchange Gains/Losses | -$265.00K |
| Net Cash Flow | $128.36M |
| Net Cash Flow, Continuing | $128.63M |
| Comprehensive Income/Loss | -$205.39M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$205.39M |
| Other Comprehensive Income/Loss | $741.00K |